Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises HELLA GmbH in connection with an investment in Gapwaves AB (publ)
Mandate

Vinge advises HELLA GmbH in connection with an investment in Gapwaves AB (publ)

June 16, 2021 Commercial Agreements Capital Markets and Public M&A Intellectual Property Automotive, Mobility and Electrification

HELLA GmbH & Co. KGaA, one of the largest manufacturers of radar in the automotive industry, has made an investment of MSEK 182.3 and entered into a licensing and development agreement with time limited exclusivity for corner and side radar with Gapwaves AB (publ).

Vinge’s team consisted primarily of David Andersson (Capital Markets & Public M&A), Malin Ohlin (Commercial Agreements), Stojan Arnerstål and Sofia Bergenstråhle (IP).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026